Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defining Standard Data Reporting in Pelvic Exenterations for Non-Rectal Cancers: A Systematic Review of Current Data Reporting.

Cancers·2025
Same author

Molecular constraints of sarcopenia in the ageing muscle.

Frontiers in aging·2025
Same author

Treatment patterns and outcomes of patients with complex Crohn's perianal fistula in five European countries: the PREFACE study.

Acta gastro-enterologica Belgica·2025
Same author

Observation of New Resonances Decaying to J/ψK^{+} and J/ψϕ.

Physical review letters·2021
Same author

Angular Analysis of the B^{+}→K^{*+}μ^{+}μ^{-} Decay.

Physical review letters·2021
Same author

Observation of a New Excited D_{s}^{+} Meson in B^{0}→D^{-}D^{+}K^{+}π^{-} Decays.

Physical review letters·2021
Same journal

Guar Gum, Partially Hydrolyzed Guar Gum, and Human Gut Health: A Narrative Review.

Reviews on recent clinical trials·2026
Same journal

The Gut Microbiota: A Functional Hub Linking Nutrition, Immunity, and Cardiovascular Health.

Reviews on recent clinical trials·2026
Same journal

Rupture of Renal Pelvis: A Case Report and Literature Review of a Rare Complication of Ureteral Lithiasis.

Reviews on recent clinical trials·2026
Same journal

Comparison between Tightrope and Hook Plate Techniques in the Treatment of Acromioclavicular Joint Dislocations: A Systematic Review and Meta-Analysis.

Reviews on recent clinical trials·2026
Same journal

Cerebral Air Embolism after Small-bore Chest Tube Insertion in a Patient with Hydropneumothorax: A Case Report.

Reviews on recent clinical trials·2026
Same journal

Pharmacological Interventions in Primary Amoebic Meningoencephalitis: Clinical Challenges and Strategic Solutions.

Reviews on recent clinical trials·2026
See all related articles

Related Experiment Video

Updated: May 17, 2026

A Rat Model of Pouchitis Following Proctocolectomy and Ileal Pouch-Anal Anastomosis Using Dextran Sulfate Sodium
04:05

A Rat Model of Pouchitis Following Proctocolectomy and Ileal Pouch-Anal Anastomosis Using Dextran Sulfate Sodium

Published on: May 31, 2024

Randomized controlled trials in pouchitis.

P Gionchetti1, A Calafiore, C Pratico

  • 1Dept of Internal medicine, University of Bologna Italy. paolo.gionchetti@unibo.it

Reviews on Recent Clinical Trials
|October 25, 2012
PubMed
Summary
This summary is machine-generated.

Pouchitis, a common ulcerative colitis complication after surgery, presents diagnostic challenges. While acute cases respond to treatment, chronic or refractory pouchitis requires further research for effective therapies.

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Related Experiment Videos

Last Updated: May 17, 2026

A Rat Model of Pouchitis Following Proctocolectomy and Ileal Pouch-Anal Anastomosis Using Dextran Sulfate Sodium
04:05

A Rat Model of Pouchitis Following Proctocolectomy and Ileal Pouch-Anal Anastomosis Using Dextran Sulfate Sodium

Published on: May 31, 2024

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Area of Science:

  • Gastroenterology
  • Surgical Complications
  • Inflammatory Bowel Disease

Background:

  • Pouchitis is the most frequent complication following proctocolectomy with ileal pouch-anal anastomosis (IPAA) in ulcerative colitis (UC) patients.
  • Diagnosis involves symptoms, endoscopic, and histological findings.
  • The etiology of pouchitis remains unclear.

Purpose of the Study:

  • To review current understanding and therapeutic approaches for pouchitis.
  • To highlight the challenges in managing refractory and chronic pouchitis.
  • To emphasize the need for further rigorous clinical trials.

Main Methods:

  • Review of existing literature on pouchitis diagnosis and treatment.
  • Analysis of current therapeutic options including antibiotics, enemas, and probiotics.
  • Identification of gaps in knowledge and research needs.

Main Results:

  • Acute pouchitis is generally responsive to treatment.
  • Refractory and chronic pouchitis pose significant therapeutic challenges.
  • Metronidazole, ciprofloxacin, budesonide enemas, and VSL#3 probiotics show efficacy in some cases.

Conclusions:

  • Medical therapy for pouchitis is largely empirical.
  • Clear definitions for treatment indications in future trials are essential.
  • Multicenter, randomized, placebo-controlled trials are needed to establish optimal treatment strategies.